Arabinosylguanine-induced apoptosis of T-lymphoblastic cells: Incorporation into DNA is a necessary step

Carlos O. Rodriguez, Varsha Gandhi

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

9-β-D-Arabinosylguanine (ara-G) is a recently introduced and effective treatment for T-cell acute lymphoblastic leukemia, but how ara-G and ara-G triphosphate (ara-GTP) kill cells is not known. We hypothesized that, in cycling T-lymphoblastoid cells, ara-G may act directly by incorporation into DNA, which may lead to apoptosis. Hence, blocking the incorporation of ara-G monophosphate (ara-GMP) into DNA may prevent apoptosis. To test this hypothesis, we performed experiments in a T-lymphoblastic leukemia cell line (CCRF-CEM) after synchronization with a double aphidicolin block. Intracellular accumulation of ara-GTP was neither cell cycle dependent nor affected by aphidicolin (53 ± 5 μM/h without aphidicolin, 50 ± 5 μM/h with aphidicolin). Cells at the G1-S boundary accumulated 75 ± 7 μM ara- GTP with minimal incorporation into DNA (5 ± 2 pmol ara-GMP/mg DNA) and had little biochemical or morphological evidence of apoptosis. In marked contrast, cells in S phase had significantly more ara-G incorporated into DNA (24 ± 4 pmol ara-GMP/mg DNA), although the cytosolic concentration of ara- GTP (85 ± 7 μM) was similar to that in the G1-enriched population. In the S-phase cells, there was a corresponding increase in apoptosis (measured as high molecular weight DNA fragmentation and morphological changes), and the incorporation of ara-GTP into DNA resulted in a >95% inhibition of DNA synthesis. There was a direct linear relationship between the number of cells in S phase and both the total number of ara-GMP molecules in DNA and the inhibition of DNA synthesis. Blocking of ara-GTP incorporation into S-phase DNA abolished biochemical and morphological features of apoptosis, even in the presence of cytotoxic level of intracellular ara-GTP. Taken together, these data demonstrate that the incorporation of ara-GTP into DNA is the critical event that mediates the induction of apoptosis in CCRF-CEM cells.

Original languageEnglish (US)
Pages (from-to)4937-4943
Number of pages7
JournalCancer Research
Volume59
Issue number19
StatePublished - Oct 1 1999
Externally publishedYes

Fingerprint

Apoptosis
DNA
Aphidicolin
S Phase
9-arabinofuranosylguanine
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
DNA Fragmentation
Precursor Cell Lymphoblastic Leukemia-Lymphoma
triphosphoric acid
Cell Cycle
Cell Count
Molecular Weight
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Arabinosylguanine-induced apoptosis of T-lymphoblastic cells : Incorporation into DNA is a necessary step. / Rodriguez, Carlos O.; Gandhi, Varsha.

In: Cancer Research, Vol. 59, No. 19, 01.10.1999, p. 4937-4943.

Research output: Contribution to journalArticle

Rodriguez, Carlos O. ; Gandhi, Varsha. / Arabinosylguanine-induced apoptosis of T-lymphoblastic cells : Incorporation into DNA is a necessary step. In: Cancer Research. 1999 ; Vol. 59, No. 19. pp. 4937-4943.
@article{dde02fac67aa42fe9a4bd65061fa6e66,
title = "Arabinosylguanine-induced apoptosis of T-lymphoblastic cells: Incorporation into DNA is a necessary step",
abstract = "9-β-D-Arabinosylguanine (ara-G) is a recently introduced and effective treatment for T-cell acute lymphoblastic leukemia, but how ara-G and ara-G triphosphate (ara-GTP) kill cells is not known. We hypothesized that, in cycling T-lymphoblastoid cells, ara-G may act directly by incorporation into DNA, which may lead to apoptosis. Hence, blocking the incorporation of ara-G monophosphate (ara-GMP) into DNA may prevent apoptosis. To test this hypothesis, we performed experiments in a T-lymphoblastic leukemia cell line (CCRF-CEM) after synchronization with a double aphidicolin block. Intracellular accumulation of ara-GTP was neither cell cycle dependent nor affected by aphidicolin (53 ± 5 μM/h without aphidicolin, 50 ± 5 μM/h with aphidicolin). Cells at the G1-S boundary accumulated 75 ± 7 μM ara- GTP with minimal incorporation into DNA (5 ± 2 pmol ara-GMP/mg DNA) and had little biochemical or morphological evidence of apoptosis. In marked contrast, cells in S phase had significantly more ara-G incorporated into DNA (24 ± 4 pmol ara-GMP/mg DNA), although the cytosolic concentration of ara- GTP (85 ± 7 μM) was similar to that in the G1-enriched population. In the S-phase cells, there was a corresponding increase in apoptosis (measured as high molecular weight DNA fragmentation and morphological changes), and the incorporation of ara-GTP into DNA resulted in a >95{\%} inhibition of DNA synthesis. There was a direct linear relationship between the number of cells in S phase and both the total number of ara-GMP molecules in DNA and the inhibition of DNA synthesis. Blocking of ara-GTP incorporation into S-phase DNA abolished biochemical and morphological features of apoptosis, even in the presence of cytotoxic level of intracellular ara-GTP. Taken together, these data demonstrate that the incorporation of ara-GTP into DNA is the critical event that mediates the induction of apoptosis in CCRF-CEM cells.",
author = "Rodriguez, {Carlos O.} and Varsha Gandhi",
year = "1999",
month = "10",
day = "1",
language = "English (US)",
volume = "59",
pages = "4937--4943",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "19",

}

TY - JOUR

T1 - Arabinosylguanine-induced apoptosis of T-lymphoblastic cells

T2 - Incorporation into DNA is a necessary step

AU - Rodriguez, Carlos O.

AU - Gandhi, Varsha

PY - 1999/10/1

Y1 - 1999/10/1

N2 - 9-β-D-Arabinosylguanine (ara-G) is a recently introduced and effective treatment for T-cell acute lymphoblastic leukemia, but how ara-G and ara-G triphosphate (ara-GTP) kill cells is not known. We hypothesized that, in cycling T-lymphoblastoid cells, ara-G may act directly by incorporation into DNA, which may lead to apoptosis. Hence, blocking the incorporation of ara-G monophosphate (ara-GMP) into DNA may prevent apoptosis. To test this hypothesis, we performed experiments in a T-lymphoblastic leukemia cell line (CCRF-CEM) after synchronization with a double aphidicolin block. Intracellular accumulation of ara-GTP was neither cell cycle dependent nor affected by aphidicolin (53 ± 5 μM/h without aphidicolin, 50 ± 5 μM/h with aphidicolin). Cells at the G1-S boundary accumulated 75 ± 7 μM ara- GTP with minimal incorporation into DNA (5 ± 2 pmol ara-GMP/mg DNA) and had little biochemical or morphological evidence of apoptosis. In marked contrast, cells in S phase had significantly more ara-G incorporated into DNA (24 ± 4 pmol ara-GMP/mg DNA), although the cytosolic concentration of ara- GTP (85 ± 7 μM) was similar to that in the G1-enriched population. In the S-phase cells, there was a corresponding increase in apoptosis (measured as high molecular weight DNA fragmentation and morphological changes), and the incorporation of ara-GTP into DNA resulted in a >95% inhibition of DNA synthesis. There was a direct linear relationship between the number of cells in S phase and both the total number of ara-GMP molecules in DNA and the inhibition of DNA synthesis. Blocking of ara-GTP incorporation into S-phase DNA abolished biochemical and morphological features of apoptosis, even in the presence of cytotoxic level of intracellular ara-GTP. Taken together, these data demonstrate that the incorporation of ara-GTP into DNA is the critical event that mediates the induction of apoptosis in CCRF-CEM cells.

AB - 9-β-D-Arabinosylguanine (ara-G) is a recently introduced and effective treatment for T-cell acute lymphoblastic leukemia, but how ara-G and ara-G triphosphate (ara-GTP) kill cells is not known. We hypothesized that, in cycling T-lymphoblastoid cells, ara-G may act directly by incorporation into DNA, which may lead to apoptosis. Hence, blocking the incorporation of ara-G monophosphate (ara-GMP) into DNA may prevent apoptosis. To test this hypothesis, we performed experiments in a T-lymphoblastic leukemia cell line (CCRF-CEM) after synchronization with a double aphidicolin block. Intracellular accumulation of ara-GTP was neither cell cycle dependent nor affected by aphidicolin (53 ± 5 μM/h without aphidicolin, 50 ± 5 μM/h with aphidicolin). Cells at the G1-S boundary accumulated 75 ± 7 μM ara- GTP with minimal incorporation into DNA (5 ± 2 pmol ara-GMP/mg DNA) and had little biochemical or morphological evidence of apoptosis. In marked contrast, cells in S phase had significantly more ara-G incorporated into DNA (24 ± 4 pmol ara-GMP/mg DNA), although the cytosolic concentration of ara- GTP (85 ± 7 μM) was similar to that in the G1-enriched population. In the S-phase cells, there was a corresponding increase in apoptosis (measured as high molecular weight DNA fragmentation and morphological changes), and the incorporation of ara-GTP into DNA resulted in a >95% inhibition of DNA synthesis. There was a direct linear relationship between the number of cells in S phase and both the total number of ara-GMP molecules in DNA and the inhibition of DNA synthesis. Blocking of ara-GTP incorporation into S-phase DNA abolished biochemical and morphological features of apoptosis, even in the presence of cytotoxic level of intracellular ara-GTP. Taken together, these data demonstrate that the incorporation of ara-GTP into DNA is the critical event that mediates the induction of apoptosis in CCRF-CEM cells.

UR - http://www.scopus.com/inward/record.url?scp=0345363112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345363112&partnerID=8YFLogxK

M3 - Article

C2 - 10519407

AN - SCOPUS:0345363112

VL - 59

SP - 4937

EP - 4943

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 19

ER -